Recommended Topic Related To:

Lacrisert

"Researchers are making progress toward understanding how some cases of glaucoma begin. A new study from the National Eye Institute reveals that myocilin—a protein linked to a significant fraction of glaucoma—is needed to insulate peri"...

Lacrisert

LACRISERT®
(hydroxypropyl cellulose ophthalmic insert)

DRUG DESCRIPTION

LACRISERT* (hydroxypropyl cellulose ophthalmic insert) is a sterile, translucent, rod-shaped, water soluble, ophthalmic insert made of hydroxypropyl cellulose, for administration into the inferior cul-de-sac of the eye.

The chemical name for hydroxypropyl cellulose is cellulose, 2-hydroxypropyl ether. It is an ether of cellulose in which hydroxypropyl groups (-CH2CHOHCH3) are attached to the hydroxyls present in the anhydroglucose rings of cellulose by ether linkages. A representative structure of the monomer is:

LACRISERT® (HYDROXYPROPYL CELLULOSE OPHTHALMIC INSERT) Structural Formula Illustration

The molecular weight is typically 1 x 106.

Hydroxypropyl cellulose is an off-white, odorless, tasteless powder. It is soluble in water below 38°C, and in many polar organic solvents such as ethanol, propylene glycol, dioxane, methanol, isopropyl alcohol (95%), dimethyl sulfoxide, and dimethyl formamide.

Each LACRISERT is 5 mg of hydroxypropyl cellulose. LACRISERT (cellulose) contains no preservatives or other ingredients. It is about 1.27 mm in diameter by about 3.5 mm long.

LACRISERT (cellulose) is supplied in packages of 60 units, together with illustrated instructions and a special applicator for removing LACRISERT (cellulose) from the unit dose blister and inserting it into the eye. A spare applicator is included in each package.

What are the precautions when taking cellulose (Lacrisert)?

Before using hydroxypropyl cellulose, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

Before using this medication, tell your doctor or pharmacist your medical history, especially of: eye surgery/injury/infection/disease.

After you apply this drug, your vision may become temporarily blurred. Do not drive, use machinery, or do any activity that requires clear vision until you are sure you can perform such activities safely.

During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor.

It is not known whether this...

Read All Potential Precautions of Lacrisert »

*Registered trademark of ATON PHARMA, INC. COPYRIGHT © ATON PHARMA, INC., 2007 All rights reserved

What are the precautions when taking cellulose (Lacrisert)?

Before using hydroxypropyl cellulose, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

Before using this medication, tell your doctor or pharmacist your medical history, especially of: eye surgery/injury/infection/disease.

After you apply this drug, your vision may become temporarily blurred. Do not drive, use machinery, or do any activity that requires clear vision until you are sure you can perform such activities safely.

During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor.

It is not known whether this...

Read All Potential Precautions of Lacrisert »

Last reviewed on RxList: 3/13/2008
This monograph has been modified to include the generic and brand name in many instances.

A A A

Lacrisert - User Reviews

Lacrisert User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Lacrisert sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.